Scientific Programme & Abstracts from the International Meeting in Pediatric Endocrinology (IMPE)

impe0096fc17.1 | Diabetes and Insulin 2 | IMPE2023

T regulatory cells with engineered chimeric antigen receptor recognizing live human beta cells as a novel tool for development of type 1 diabetes therapies.

Radichev Ilian , Sevigny Jean , Pelletier Julie , Mathews Clayton , Griffin Kurt , Savinov Alexei

Objectives/Background: Type 1 Diabetes (T1D) manifests as a loss of insulin secretion due to autoimmune destruction of β-cells by self-reactive T effector lymphocytes. Suppression of autoreactive T effectors by regulatory T cells (Tregs) is a key mechanism of peripheral self-tolerance. T1D subjects have documented numerical and functional Tregs impairment. Recent early-stage clinical trials with adoptively transferred ex vivo-expanded autologous Tregs sho...